- Home
- KNDI vs ADAG Comparison
KNDI vs ADAG Comparison
Compare KNDI & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- ADAG
- Stock Information
- Founded
- KNDI 2002
- ADAG 2011
- Country
- KNDI China
- ADAG China
- Employees
- KNDI N/A
- ADAG N/A
- Industry
- KNDI Auto Manufacturing
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- KNDI Consumer Discretionary
- ADAG Health Care
- Exchange
- KNDI Nasdaq
- ADAG Nasdaq
- Market Cap
- KNDI 96.3M
- ADAG 91.4M
- IPO Year
- KNDI N/A
- ADAG 2021
- Fundamental
- Price
- KNDI $1.15
- ADAG $1.89
- Analyst Decision
- KNDI
- ADAG Strong Buy
- Analyst Count
- KNDI 0
- ADAG 1
- Target Price
- KNDI N/A
- ADAG $8.00
- AVG Volume (30 Days)
- KNDI 98.2K
- ADAG 88.1K
- Earning Date
- KNDI 08-15-2025
- ADAG 07-24-2025
- Dividend Yield
- KNDI N/A
- ADAG N/A
- EPS Growth
- KNDI N/A
- ADAG N/A
- EPS
- KNDI N/A
- ADAG N/A
- Revenue
- KNDI $127,569,613.00
- ADAG $103,204.00
- Revenue This Year
- KNDI N/A
- ADAG $6,488.89
- Revenue Next Year
- KNDI N/A
- ADAG $57.50
- P/E Ratio
- KNDI N/A
- ADAG N/A
- Revenue Growth
- KNDI 3.21
- ADAG N/A
- 52 Week Low
- KNDI $0.89
- ADAG $1.33
- 52 Week High
- KNDI $2.07
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- KNDI 54.64
- ADAG 50.07
- Support Level
- KNDI $1.09
- ADAG $1.74
- Resistance Level
- KNDI $1.16
- ADAG $1.99
- Average True Range (ATR)
- KNDI 0.07
- ADAG 0.10
- MACD
- KNDI 0.01
- ADAG -0.01
- Stochastic Oscillator
- KNDI 74.86
- ADAG 41.67
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.